“Drugs were manufactured in April for 58.1 billion rubles, which is 35.9% more than in April 2021, but 9.4% less than in March 2022,” TASS said in a statement.

It is noted that in January-April, medicines worth 229 billion rubles were produced in Russia.

Earlier, Rosstat announced a decrease in consumer prices by 0.02% over the week.